- CA$121.89m
- CA$118.39m
- CA$109.85m
Brief: Imaflex Announces Strong Q4 And FY2021 Results
Brief: Imaflex Announces Resignation Of Director Mario Settino
Brief: Imaflex Posts Qtrly Revenue Of $29.5 Million, Up 28.6%
Brief: Imaflex Reports Q2 EPS Of $0.04
Brief: Imaflex Reports Strong Q1 2021 Results And Provides Business Update
Brief: Imaflex Reports Q4 Net Income of $1.7 Mln
Brief: Imaflex Announces Positive Independent Results For The ADVASEAL Release Study
Brief: Imaflex Reports Q3 2020 Results
Brief: Imaflex Announces That The Advaseal Release Study Is Underway
Brief: Imaflex Reports Positive Final Independent Results From Advaseal Efficacy Field Trial
Brief: Imaflex Reports Q2 2020 Results And Provides Business Update
Brief: Imaflex Reports Solid Q1 2020 Results And Provides Business Update
Brief: Imaflex Continues To See Positive Results From Advaseal® Field Trial
Brief: Imaflex reports Qtrly Earnings Per Share $0.01
Brief: Imaflex Announces Positive Interim Results For Advaseal Field Trial
Brief: Imaflex Provides Update On Impact Of Coronavirus
Brief: Imaflex Reports Q3 Earnings Per Share $0.01
Brief: Imaflex Reports Q2 Diluted EPS C$0.00
Brief: Imaflex Inc Posts Qtrly Earnings Per Share $0.01